Biochemical parameters indicating poor metabolic glycemic control at the diagnosis of GDM can also predict the need of insulin therapy: HbA1c at diagnosis >5.5% and elevated 1-h and 2-h plasma glucose level at OGTT has been reported to be predictors of pharmacological treatment (13, 14). The gene discussed is INS; the disease is gestational diabetes.